Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.320 | 14 | 103712930 | splice region variant | T/C | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2011 | 2016 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2011 | 2016 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.240 | 14 | 103699590 | intron variant | T/A;C | snv | 0.31 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.200 | 14 | 103698934 | missense variant | C/A;T | snv | 4.5E-06; 4.3E-04 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.200 | 14 | 103698934 | missense variant | C/A;T | snv | 4.5E-06; 4.3E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.200 | 14 | 103698934 | missense variant | C/A;T | snv | 4.5E-06; 4.3E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.200 | 14 | 103698934 | missense variant | C/A;T | snv | 4.5E-06; 4.3E-04 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.200 | 14 | 103698934 | missense variant | C/A;T | snv | 4.5E-06; 4.3E-04 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 14 | 103707128 | missense variant | C/T | snv | 1.4E-03 | 6.3E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
0.925 | 0.080 | 14 | 103707128 | missense variant | C/T | snv | 1.4E-03 | 6.3E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||
|
1.000 | 0.080 | 14 | 103704128 | 3 prime UTR variant | G/A | snv | 5.2E-02 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 14 | 103699345 | intron variant | A/C | snv | 7.1E-03 | 2.2E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
14 | 103698185 | 3 prime UTR variant | T/C | snv | 1.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
14 | 103698185 | 3 prime UTR variant | T/C | snv | 1.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.080 | 14 | 103712895 | 5 prime UTR variant | G/A | snv | 1.2E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 14 | 103712895 | 5 prime UTR variant | G/A | snv | 1.2E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
14 | 103708630 | missense variant | G/A | snv | 2.8E-05 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
0.882 | 0.080 | 14 | 103701208 | 3 prime UTR variant | G/A | snv | 0.59 | 0.61 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.882 | 0.080 | 14 | 103701208 | 3 prime UTR variant | G/A | snv | 0.59 | 0.61 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.882 | 0.080 | 14 | 103701208 | 3 prime UTR variant | G/A | snv | 0.59 | 0.61 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |